Study Effect of Iron in Patient with Heart Disease
DOI:
https://doi.org/10.51699/ijhsms.v2i10.2747Abstract
The study conducted on too Iraqi patient with chronic atherosclerosis at age rang (29-70years) in Baquba teaching hospital in (center care unit) during the period from 25 September 2020to may 2021. The patients divided in (55 mans and 45 patients ) the total patient divided in tow groups according the treatment (30) of total patient under go to treatment for two to three days after atherosclerosis and 70 patient in same day of diagnosis of atherosclerosis . it is noticed Decrease in electrolytes Iron values.
Downloads
References
N. Ebner, S. von Haehling, Why is iron deficiency recognised as an important comorbidity in heart failure? Card. Fail. Rev. 5 (3) (2019) 173–175.
I.S. Anand, P. Gupta, Anemia and iron deficiency in heart failure: current concepts and emerging therapies, Circulation 138 (1) (2018) 80–98.
I.T. Klip, J. Comin-Colet, A.A. Voors, P. Ponikowski, C. Enjuanes, W. Banasiak, D. J. Lok, P. Rosentryt, A. Torrens, L. Polonski, D.J. van Veldhuisen, P. van der Meer, E.A. Jankowska, Iron deficiency in chronic heart failure: an international pooled analysis, Am. Heart J. 165 (2013) 575–582.
J. Comin-Colet, C. Enjuanes, G. Gonzalez, A. Torrens, M. Cladellas, O. Merono, N. Ribas, S. Ruiz, M. Gomez, J.M. Verdu, J. Bruguera, Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status, Eur. J. Heart Fail. 15 (2013) 1164–1172.
E.A. Jankowska, P. Rozentryt, A. Witkowska, J. Nowak, O. Hartmann, B. Ponikowska, L. Borodulin-Nadzieja, S. von Haehling, W. Doehner, W. Banasiak, L. Polonski, G. Filippatos, S.D. Anker, P. Ponikowski, Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure, J. Card Fail. 17 (2011) 899–906. N. Yamani et al. IJC Heart & Vasculature 36 (2021) 100871 7
D.O. Okonko, A.K. Mandal, C.G. Missouris, P.A. Poole-Wilson, Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival, J. Am. Coll. Cardiol. 58 (2011) 1241–1251.
X. Zhou, W. Xu, Y. Xu, Z. Qian, Iron supplementation improves cardiovascular outcomes in patients with heart failure, Am. J. Med. 132 (8) (2019) 955–963.
S. von Haehling, N. Ebner, R. Evertz, P. Ponikowski, S.D. Anker, Iron deficiency in heart failure: an overview, JACC Heart Fail. 7 (1) (2019) 36–46.
C.W. Yancy, M. Jessup, B. Bozkurt, et al., 2017 ACC/AHA/HFSA Focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America, J. Am. Coll. Cardiol. 70 (2017) 776–803.
P. Ponikowski, A.A. Voors, S.D. Anker, et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur. Heart J. 37 (27) (2016) 2129–2200.
P. Ponikowski, D.J. van Veldhuisen, J. Comin-Colet, et al., Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†, Eur. Heart J. 36 (11) (2015) 657–668.
S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, T.F. Lüscher, B. Bart, W. Banasiak, J. Niegowska, B.A. Kirwan, C. Mori, Rothe B von Eisenhart, S.J. Pocock, P.A. Poole-Wilson, P. Ponikowski, FAIR-HF Trial Investigators, Ferric carboxymaltose in patients with heart failure and iron deficiency, N. Engl. J. Med. 361 (25) (2009) 2436–2448.
P. Ponikowski, B.A. Kirwan, M.S. Anker, et al., Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre randomised, controlled, double-blind trial, Lancet (2020).
S.D. Anker, J. Comin Colet, G. Filippatos, et al., Ferric carboxymaltose in patients with heart failure and iron deficiency, N. Engl. J. Med. 361 (25) (2009) 2436–2448
